News
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
18h
Live Science on MSNCan weight loss drugs help you drink less alcohol?There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
3h
Futurism on MSNWeight Loss Influencer's Fans Angry When She Reveals How She Was Really Pulling It OffA wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy ...
GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...
19hon MSN
Ozempic, while effective for weight loss, is linked to emerging dental problems termed \"Ozempic teeth.\" Patients report dry ...
I shed two stone on weight-loss drugs – then got ‘Ozempic tongue’ - COMMENT: Although the drugs help me shift unhealthy ...
Weight loss jabs could reduce the risk of up to 14 types of cancer, new research has found. Mounjaro, Ozempic and other ...
VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...
A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.
As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.
19h
News Nation on MSNStudy: Weight loss drugs could reduce cancer riskThe data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results